Maryland Resident Files $1 Million Reglan Lawsuit
On January 31, 2012, Maryland resident Dolores Sams filed a $1 million Reglan side effects lawsuit in the U.S. District Court of Maryland against UCB, Inc. Sams, represented by her Reglan lawyer, demands financial compensation for hardships and injuries related to her Reglan neurological side effects.
Plaintiff seeks damages for Reglan neurological side effects
Sams started taking a generic form of Reglan (metoclopramide) in 2003 to treat a gastro esophageal reflux condition. In 2009, she stopped taking her 10 mg dosage after meals when her doctor diagnosed her with Reglan tardive dyskinesia, an involuntary movement disorder. Sams claims in her Reglan lawsuit to suffer from uncontrolled tongue movements, cognitive impairments, loss of balance and peripheral neuropathy, which is a form of nerve damage.
As a result of her alleged Reglan neurological side effects, Sams seeks $1 million in compensatory damages for her injuries, medical expenses, loss of wages, and reduced earning capacity. Against defendant UCB the plaintiff brings claims of strict liability, negligence, defective design, and breach of warranty.
Reglan neurological side effects
Reglan was approved by the Food and Drug Administration (FDA) to treat symptoms associated with gastroparesis, which prevents food from traveling through the digestive track. It is also used to treat heartburn and acid reflux.
Reglan plaintiffs claim the drug, or its generic counterpart metoclopramide, caused them to develop Reglan neurological side effects, including Reglan tardive dyskinesia, blepharospasm, ocular deviation, secondary Parkinsons disease, cervical dystonia, and neuroleptic malignant syndrome.
Reglan tardive dyskinesia is perhaps the most commonly cited side effect by plaintiffs. The condition often mirrors Tourette’s syndrome in terms of the size and breadth of involuntary muscle movements. Because Reglan is designed to interfere with the nervous system, the medical community believes that taking it for too long can alter its normal functions.
Failure to warn cited in Reglan side effects lawsuit
Sams makes claims against UCB on the grounds that it failed to warn her and other consumers about risks associated with taking Reglan and other generic forms of the drug, including the possibility of developing Reglan neurological side effects.
Judge Roger W. Titus is presiding over Sams vs. UCB, Incorporated.